Mutations in dystrophin affecting the plasma membrane and causing myofiber loss could lead to the pathologic substrate favoring myocardial atrophy and fibrofatty replacement, which are the main pathogenetic mechanisms described in ARVC [78]. Here, DMD is linked to arrhythmogenic right ventricular cardiomyopathy.